Table. Core indicators for the World Health Organization’s monitoring and evaluation framework for hepatitis B and hepatitis C virus elimination 2016–2021.

Indicator number	Indicator name
C1	Prevalence of chronic HBV and HCV infection
C2	Infrastructure for HBV and HCV testing
C3	a. Coverage of timely hepatitis B vaccine birth dose (within 24 hours) and other interventions to prevent mother-to-child transmission of HBV        b. Coverage of third-dose hepatitis B vaccine among infants
C4	Needle–syringe distribution
C5	Facility level injection safety
C6	People living with HCV and/or HBV diagnosed
C7	a. Treatment coverage for hepatitis B patients                   b. Treatment initiation for hepatitis C patients
C8	a. Viral suppression for chronic hepatitis B patients treated                   b. Cure for chronic hepatitis C patients treated
C9	a. Cumulated incidence of HBV infection in children 5 years of age                   b. Incidence of HCV infection
C10	Deaths from hepatocellular carcinoma, cirrhosis and liver diseases attributable to HBV and HCV infection

HBV: hepatitis B virus; HCV: hepatitis C virus.

Source: [6].